ADR120S (3750.T) Stock Price

ADR120S Price

CLOSED
793.00
​
Market closed

Revenue at ADR120S has contracted by 26.1% per year over the past 19 years to 50.99 M JPY. Earnings per share have declined at 9.6% per year over the last 13 years. For ADR120S, the net margin of -778.4% is down versus -5.8% a few years ago. At today's price the dividend yield works out to roughly 1.26%. The payout ratio is around 22% of earnings.

ADR120S stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ADR120S business model & stock analysis

ADR120S Inc generates revenue through its Real Asset segment, which involves buying and selling real estate, developing and operating hotels, and investing in real estate projects. The Medical segment focuses on regenerative medicine, selling medical equipment like the Celusion centrifuge and Celusion cell therapy kit, and providing cell therapy services. The company serves clients in real estate development, hotel operations, and healthcare sectors, with products targeting medical facilities and clinics specializing in regenerative treatments. The Real Asset segment handles property transactions, hotel management, and real estate investments, while the Medical segment offers cell therapy solutions through its branded products. Both segments target businesses seeking to expand in real estate or adopt advanced medical technologies, with the Celusion products being key revenue drivers in the healthcare market.

Frequently asked questions about ADR120S

Converted at the current exchange rate, the ADR120S share trades at 4.51 EUR (793.00 JPY).

The revenue of ADR120S is 50.99 M JPY. This figure is based on current financial data and reflects the company's business performance.

The profit of ADR120S is -396.90 M JPY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of ADR120S is currently -17.84. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the ADR120S stock.

The price-to-sales ratio (P/S) of ADR120S is currently 138.85. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the ADR120S stock.

The Eulerpool Quality Score for ADR120S is 2/10.

The ISIN of ADR120S is JP3426500009. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of ADR120S is 3750.T. The ticker symbol is used to trade ADR120S shares on the stock exchange.

Fair ValueTerminal
721.63 JPY
Over-/UndervaluationTerminal
Fairly valued
Industry
Real Estate Management & Development
Number of shares
Employees
Revenue per Employee
796,687.50 JPY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website cytori.co.jp
Country
Currency
JPY
Initial public offering
Oct 1, 2004
ISIN
JP3426500009
Cusip
J7166E112
Market capitalization
7.08 B JPYMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2027
—
P/Se
—
EV/EBIT
—
P/B Ratio
321.52
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-1,802.06 %
Dividend
Dividend yield
0.00 %
Est. Dividend Yield
2.52 %
Payout Ratio
23.67 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
15.32 %
Last updated Nov 2, 2026, 6:15 PM

ADR120S Peer Group

ADR120S FIGI

3750:JP · BBG000JMKG483750:JT · BBG000JMKH553750:JJ · BBG000JMLSL23750:JE · BBG000JMLVJ83750:JI · BBG000JMLW243750:JU · BBG002QKCDC73750:JW · BBG00875HC993750:JV · BBG0193R9LC7

All fundamentals and in-depth analysis of ADR120S

Our stock analysis for ADR120S stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ADR120S. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.